Arkansas Legal Resource Navigator

42 U.S.C. § 283n — Shared Instrumentation Grant Program

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 283n — Shared Instrumentation Grant Program

**(a) Requirements for grants** In determining whether to award a grant to an applicant under the Shared Instrumentation Grant Program, the Director of NIH, acting through the Office of the Director of NIH, shall consider— (1) the extent to which an award for the specific instrument involved would meet the scientific needs and enhance the planned research endeavors of the major users by providing an instrument that is unavailable or to which availability is highly limited; (2) with respect to the instrument involved, the availability and commitment of the appropriate technical expertise within the major user group or the applicant institution for use of the instrumentation; (3) the adequacy of the organizational plan for the use of the instrument involved and the internal advisory committee for oversight of the applicant, including sharing arrangements if any; (4) the applicant’s commitment for continued support of the utilization and maintenance of the instrument; and (5) the extent to which the specified instrument will be shared and the benefit of the proposed instrument to the overall research community to be served. **(b) Peer review** In awarding grants under the program described in subsection (a), the Director of NIH, acting through the Office of the Director of NIH, shall comply with the peer review requirements in [section 289a of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section289a&num=0&edition=prelim).

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 283n

Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: d6e08fab15a887c1afc40eac8cb28c73b194d5f3c90f6cf6ab9eafab5296ce29. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Open the recorded source website ↗

Record provenance

Stable record: federal_law:legal_authorities:record_usc_088bd73d6ea384b805077b88
Source file: Laws/federal/codes/united-states-code/title-42/section-283n-shared-instrumentation-grant-program--66bed0f6dd.md
Pages: Not recorded – Not recorded
Passage SHA-256: 8f8c150ee329a510d83bd353aefec1c82cf74fce161dbeca13d41350c4c4b24a

Source location: Title 42, Chapter 6A, § 283n; chapter-6a-public-health-service.md

Stored source content

**(a) Requirements for grants** In determining whether to award a grant to an applicant under the Shared Instrumentation Grant Program, the Director of NIH, acting through the Office of the Director of NIH, shall consider— (1) the extent to which an award for the specific instrument involved would meet the scientific needs and enhance the planned research endeavors of the major users by providing an instrument that is unavailable or to which availability is highly limited; (2) with respect to the instrument involved, the availability and commitment of the appropriate technical expertise within the major user group or the applicant institution for use of the instrumentation; (3) the adequacy of the organizational plan for the use of the instrument involved and the internal advisory committee for oversight of the applicant, including sharing arrangements if any; (4) the applicant’s commitment for continued support of the utilization and maintenance of the instrument; and (5) the extent to which the specified instrument will be shared and the benefit of the proposed instrument to the overall research community to be served. **(b) Peer review** In awarding grants under the program described in subsection (a), the Director of NIH, acting through the Office of the Director of NIH, shall comply with the peer review requirements in [section 289a of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section289a&num=0&edition=prelim).

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 289a — Peer review requirements

**(a) Applications for biomedical and behavioral research grants, cooperative agreements, and contracts; regulations** (1) The Secretary, acting through the Director of NIH, shall by regulation require appropriate technical and scientific peer review of— (A) applications made for grants and cooperative agreements under this chapter for biomedical and behavioral research; and (B) applications made for biomedical and behavioral research and development contracts to be administered through the National Institutes of Health. (2) Regulations promulgated under paragraph (1) shall require that the review of applications made for grants, contracts, and cooperative agreements required by the regulations be conducted— (A) to the extent practical, in a manner consistent with the system for technical and scientific peer review applicable on November 20, 1985, to grants under this chapter for biomedical and behavioral research, and (B) to the extent practical, by technical and scientific peer review groups performing such review on or before November 20, 1985, and shall authorize such review to be conducted by groups appointed under sections 282(b)(16) and 284(c)(3) of this title. **(b) Periodic review of research at National Institutes of Health** The Director of NIH shall establish procedures for periodic technical and scientific peer review of research at the National Institutes of Health. Such procedures shall require that— (1) the reviewing entity be provided a written description of the research to be reviewed, and (2) the reviewing entity provide the advisory council of the national research institute involved with such description and the results of the review by the entity, and shall authorize such review to be conducted by groups appointed under sections

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 289a

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 287 — National Center for Advancing Translational Sciences

**(a) Purpose** The purpose of the National Center for Advancing Translational Sciences (in this subpart referred to as the “Center”) is to advance translational sciences, including by— (1) coordinating and developing resources that leverage basic research in support of translational science; and (2) developing partnerships and working cooperatively to foster synergy in ways that do not create duplication, redundancy, and competition with industry activities. **(b) Clinical trial activities** (1) **In general** — The Center may develop and provide infrastructure and resources for all phases of clinical trials research. Except as provided in paragraph (2), the Center may support clinical trials only through the end of phase IIB. (2) **Exception** — The Center may support clinical trial activities through the end of phase III for a treatment for a rare disease or condition (as defined in [section 360bb of title 21](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section360bb&num=0&edition=prelim)) so long as— (A) the Center gives public notice for a period of at least 120 days of the Center’s intention to support the clinical trial activities in phase III; (B) no public or private organization provides credible written intent to the Center that the organization has timely plans to further the clinical trial activities or conduct clinical trials of a similar nature beyond phase IIB; and (C) the Center ensures that support of the clinical trial activities in phase III will not increase the Federal Government’s liability beyond the award value of the Center’s support. **(c) Biennial report** The Center shall publish a report on a biennial basis that, with respect to all research supported by the Center, includes a complete list of— (1) th

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 287

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 283n — Shared Instrumentation Grant Program

Page 668 TITLE 42—THE PUBLIC HEALTH AND WELFARE § 283n (3) Biennial report Not later than 180 days after November 27, 2013, the Director of the National Institutes of Health shall submit to the Committee on Health, Education, Labor, and Pensions and the Committee on Appropriations of the Sen- ate and the Committee on Energy and Com- merce and the Committee on Appropriations in the House of Representatives a report, to be updated biennially, regarding— (A) the care, maintenance, and transpor- tation of the chimpanzees under the owner- ship or control of the National Institutes of Health; (B) costs related to such care, mainte- nance, and transportation, and any other re- lated costs; and (C) the research status of such chim- panzees. (July 1, 1944, ch. 373, title IV, § 404K, formerly § 481C, as added Pub. L. 106–551, § 2, Dec. 20, 2000, 114 Stat. 2752; amended Pub. L. 110–170, § 2(a), Dec. 26, 2007, 121 Stat. 2465; renumbered § 404K and amended Pub. L. 112–74, div. F, title II, § 221(b)(3), Dec. 23, 2011, 125 Stat. 1088; Pub. L. 113–55, title III, § 302(a), (c), Nov. 27, 2013, 127 Stat. 646, 647.) Editorial Notes REFERENCES IN TEXT The Animal Welfare Act, referred to in subsecs. (d)(2)(D), (3)(B) and (e)(3)(A)(ix), is Pub. L. 89–544, Aug. 24, 1966, 80 Stat. 350, which is classified generally to chapter 54 (§ 2131 et seq.) of Title 7, Agriculture. For complete classification of this Act to the Code, see Short Title note set out under section 2131 of Title 7 and Tables. Section 3 of the Chimpanzee Health Improvement, Maintenance, and Protection Act, referred to in subsec. (d)(4)(A), is section 3 of Pub. L. 106–551, which is set out as a note below. CODIFICATION Section was formerly classified to section 287a–3a of this title. November 27,

Source: Supplied 2024 U.S. Code historical extraction · 42 U.S.C. § 283n

Stored review status: historical_2024_not_currentness_verified. Same stored citation; legal effect and authority still require review.